PL4387730T3 - Stałe postaci inhibitora rock - Google Patents
Stałe postaci inhibitora rockInfo
- Publication number
- PL4387730T3 PL4387730T3 PL23776436.0T PL23776436T PL4387730T3 PL 4387730 T3 PL4387730 T3 PL 4387730T3 PL 23776436 T PL23776436 T PL 23776436T PL 4387730 T3 PL4387730 T3 PL 4387730T3
- Authority
- PL
- Poland
- Prior art keywords
- rock inhibitor
- inhibitor constants
- constants
- rock
- inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2213103.1A GB202213103D0 (en) | 2022-09-08 | 2022-09-08 | Crystalline form of a rock inhibitor |
| GBGB2214708.6A GB202214708D0 (en) | 2022-10-06 | 2022-10-06 | Crystalline form of a rock inhibitor |
| PCT/GB2023/052341 WO2024052704A1 (en) | 2022-09-08 | 2023-09-08 | Solid forms of a rock inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4387730T3 true PL4387730T3 (pl) | 2025-09-22 |
Family
ID=88188945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23776436.0T PL4387730T3 (pl) | 2022-09-08 | 2023-09-08 | Stałe postaci inhibitora rock |
Country Status (19)
| Country | Link |
|---|---|
| EP (2) | EP4520746A3 (pl) |
| JP (2) | JP2024534810A (pl) |
| KR (1) | KR20250057882A (pl) |
| CN (1) | CN119894884A (pl) |
| AU (1) | AU2023336823A1 (pl) |
| CA (1) | CA3262882A1 (pl) |
| DK (1) | DK4387730T3 (pl) |
| ES (1) | ES3040251T3 (pl) |
| FI (1) | FI4387730T3 (pl) |
| HR (1) | HRP20251018T1 (pl) |
| HU (1) | HUE073310T2 (pl) |
| IL (1) | IL319110A (pl) |
| LT (1) | LT4387730T (pl) |
| MX (1) | MX2025002776A (pl) |
| PL (1) | PL4387730T3 (pl) |
| PT (1) | PT4387730T (pl) |
| SI (1) | SI4387730T1 (pl) |
| SM (1) | SMT202500313T1 (pl) |
| WO (1) | WO2024052704A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202403179D0 (en) | 2024-03-05 | 2024-04-17 | Redx Pharma Plc | Method of making kinase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL366011A1 (pl) * | 2000-09-29 | 2005-01-24 | Bristol-Myers Squibb Company | Dynamiczy rozdział izomerów i rozdzielone izomery |
| AR065804A1 (es) * | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| SG11201400058PA (en) * | 2011-08-31 | 2014-03-28 | Amakem Nv | Novel rock kinase inhibitors |
| SMT201700317T1 (it) | 2013-01-29 | 2017-09-07 | Redx Pharma Plc | Derivati piridinici in qualità di inibitori rock teneri |
| EP2957575B1 (en) * | 2013-02-12 | 2017-10-18 | National University Corporation Kanazawa University | Optically active poly(diphenylacetylene) compound, preparation method therefor, and use thereof as optical isomer separating agent |
| JP6916796B2 (ja) * | 2016-01-22 | 2021-08-11 | ヤンセン ファーマシューティカ エヌ．ベー． | Ｎｉｋ阻害剤としての新たな６員のヘテロ芳香族置換シアノインドリン誘導体 |
| WO2018178243A2 (en) * | 2017-04-01 | 2018-10-04 | Adeptio Pharmaceuticals Limited | Pharmaceutical compositions |
| MA56390A (fr) * | 2019-06-27 | 2022-05-04 | Biogen Ma Inc | Dérivés d'imidazo[1,2-a]pyridinyle et leur utilisation dans le traitement d'une maladie |
-
2023
- 2023-09-08 LT LTEPPCT/GB2023/052341T patent/LT4387730T/lt unknown
- 2023-09-08 FI FIEP23776436.0T patent/FI4387730T3/fi active
- 2023-09-08 AU AU2023336823A patent/AU2023336823A1/en active Pending
- 2023-09-08 HU HUE23776436A patent/HUE073310T2/hu unknown
- 2023-09-08 WO PCT/GB2023/052341 patent/WO2024052704A1/en not_active Ceased
- 2023-09-08 CN CN202380063859.4A patent/CN119894884A/zh active Pending
- 2023-09-08 SM SM20250313T patent/SMT202500313T1/it unknown
- 2023-09-08 PT PT237764360T patent/PT4387730T/pt unknown
- 2023-09-08 DK DK23776436.0T patent/DK4387730T3/da active
- 2023-09-08 IL IL319110A patent/IL319110A/en unknown
- 2023-09-08 HR HRP20251018TT patent/HRP20251018T1/hr unknown
- 2023-09-08 CA CA3262882A patent/CA3262882A1/en active Pending
- 2023-09-08 ES ES23776436T patent/ES3040251T3/es active Active
- 2023-09-08 JP JP2024510429A patent/JP2024534810A/ja active Pending
- 2023-09-08 EP EP25152670.3A patent/EP4520746A3/en active Pending
- 2023-09-08 EP EP23776436.0A patent/EP4387730B1/en active Active
- 2023-09-08 SI SI202330043T patent/SI4387730T1/sl unknown
- 2023-09-08 PL PL23776436.0T patent/PL4387730T3/pl unknown
- 2023-09-08 KR KR1020257010569A patent/KR20250057882A/ko active Pending
-
2025
- 2025-03-07 MX MX2025002776A patent/MX2025002776A/es unknown
- 2025-03-11 JP JP2025038352A patent/JP2025090729A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SMT202500313T1 (it) | 2025-09-12 |
| PT4387730T (pt) | 2025-08-27 |
| IL319110A (en) | 2025-04-01 |
| JP2025090729A (ja) | 2025-06-17 |
| CA3262882A1 (en) | 2024-03-14 |
| FI4387730T3 (fi) | 2025-08-25 |
| LT4387730T (lt) | 2025-09-10 |
| EP4387730B1 (en) | 2025-05-28 |
| DK4387730T3 (da) | 2025-09-01 |
| ES3040251T3 (en) | 2025-10-29 |
| AU2023336823A1 (en) | 2025-02-20 |
| SI4387730T1 (sl) | 2025-10-30 |
| KR20250057882A (ko) | 2025-04-29 |
| JP2024534810A (ja) | 2024-09-26 |
| EP4387730A1 (en) | 2024-06-26 |
| MX2025002776A (es) | 2025-04-02 |
| CN119894884A (zh) | 2025-04-25 |
| HRP20251018T1 (hr) | 2025-10-24 |
| EP4520746A2 (en) | 2025-03-12 |
| WO2024052704A1 (en) | 2024-03-14 |
| HUE073310T2 (hu) | 2026-01-28 |
| EP4520746A3 (en) | 2025-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4495113A4 (en) | KIF18A INHIBITOR | |
| EP4110333A4 (en) | Sos1 inhibitors | |
| EP4216951A4 (en) | KRAS G12D INHIBITORS | |
| EP4434979A4 (en) | KIF18A INHIBITOR | |
| DK4337652T3 (da) | NLRP3-hæmmere | |
| EP4332103A4 (en) | ATR INHIBITOR COMPOUND CONTAINING A SULFOXIMINE | |
| EP4197538A4 (en) | Egfr inhibitor | |
| PL4363406T3 (pl) | Inhibitory inflamasomu nlrp3 | |
| IL314887A (en) | Inhibitors of parg | |
| DK4301468T3 (da) | Fgfr3-inhibitorforbindelser | |
| IL315027A (en) | Inhibitors of nlrp3 | |
| EP4358963A4 (en) | SOS1 INHIBITORS | |
| EP3901156A4 (en) | NITROOXY DERIVATIVE OF ROCK KINASE INHIBITOR | |
| EP4247372A4 (en) | PLASMA KALLICREIN INHIBITORS | |
| EP4263502C0 (en) | SARS-COV-2 MPRO INHIBITOR COMPOUNDS | |
| EP4541491A4 (en) | FOREST | |
| IL321260A (en) | Polq inhibitors | |
| EP4003986A4 (en) | Inhibitor compounds | |
| EP4168398A4 (en) | TYK-2 INHIBITOR | |
| EP4226919A4 (en) | FERROPTOSIS INHIBITOR | |
| EP4210694A4 (en) | PLASMA KALLICREIN INHIBITORS | |
| PL4387730T3 (pl) | Stałe postaci inhibitora rock | |
| EP4257795C0 (en) | ANCHOR BOLT | |
| DK4323338T3 (da) | TEAD-hæmmere | |
| DK4192814T3 (da) | Transglutaminase-hæmmere |